Magabulo, Baby Girl .

HRN: 28-85-71  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2026
CEFTAZIDIME 1GM (VIAL)
04/14/2026
04/21/2026
IV
45mg
Q12hours
T/c Neonatal Sepsis
Checking Initial Appropriateness 
04/14/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/14/2026
04/21/2026
IV
23mg
Q36hours
T/c Neonatal Sepsis
Checking Initial Appropriateness 
04/16/2026
MUPIROCIN 2%, 15G (TUBE)
04/16/2026
04/23/2026
TOPICAL
15g
TID
Phlebitis
Checking Initial Appropriateness 
04/21/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/21/2026
04/28/2026
IV
150mg
Q8h
Neonatal Sepsis
Checking Initial Appropriateness 
05/06/2026
CLINDAMYCIN 150MG (CAP)
05/06/2026
05/13/2026
PO
7.5mg Ppcap
Q8hours
Neonatal Sepsis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: